Total Payments
$21,369
2024 Payments
$7,150
Companies
48
Transactions
933
Medicare Patients
7,123
Medicare Billing
$869,678
Payment Breakdown by Category
Food & Beverage$16,089 (75.3%)
Education$4,448 (20.8%)
Travel$811.23 (3.8%)
Other$20.92 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,089 | 911 | 75.3% |
| Education | $4,448 | 18 | 20.8% |
| Travel and Lodging | $811.23 | 3 | 3.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $20.92 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| INTUITIVE SURGICAL, INC. | $4,827 | 6 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,583 | 132 | $0 (2024) |
| GlaxoSmithKline, LLC. | $2,472 | 188 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $1,128 | 52 | $0 (2024) |
| United Therapeutics Corporation | $1,034 | 43 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,003 | 58 | $0 (2024) |
| Grifols USA, LLC | $802.88 | 46 | $0 (2024) |
| Insmed, Inc. | $665.51 | 25 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $611.11 | 32 | $0 (2024) |
| Gilead Sciences, Inc. | $563.37 | 51 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,150 | 114 | INTUITIVE SURGICAL, INC. ($4,827) |
| 2023 | $1,782 | 94 | AstraZeneca Pharmaceuticals LP ($338.45) |
| 2022 | $2,252 | 112 | AstraZeneca Pharmaceuticals LP ($374.84) |
| 2021 | $1,974 | 108 | GlaxoSmithKline, LLC. ($338.65) |
| 2020 | $1,903 | 107 | GlaxoSmithKline, LLC. ($330.72) |
| 2019 | $1,914 | 102 | AstraZeneca Pharmaceuticals LP ($364.10) |
| 2018 | $2,001 | 148 | AstraZeneca Pharmaceuticals LP ($410.34) |
| 2017 | $2,394 | 148 | Respiratory Technologies, Inc. ($404.40) |
All Payment Transactions
933 individual payment records from CMS Open Payments — Page 1 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $7.32 | General |
| Category: HFCWO | ||||||
| 12/13/2024 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Airway Clearance Device | ||||||
| 12/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: Immunology | ||||||
| 12/10/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Education | In-kind items and services | $1,500.00 | General |
| Category: SURGERY | ||||||
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Respiratory | ||||||
| 12/06/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/05/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $34.87 | General |
| Category: Respiratory | ||||||
| 12/03/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Education | In-kind items and services | $99.99 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 11/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $10.03 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $7.53 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.75 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/11/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $25.80 | General |
| Category: Cardiology | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Respiratory | ||||||
| 11/05/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/31/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $27.88 | General |
| Category: Pulmonology | ||||||
| 10/31/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $10.80 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/29/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.63 | General |
| 10/28/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Education | In-kind items and services | $2,500.00 | General |
| Category: SURGERY | ||||||
| 10/28/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: SURGERY | ||||||
| 10/25/2024 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Airway Clearance Device | ||||||
| 10/23/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $50.35 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/23/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $4.45 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/22/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $35.62 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,752 | 2,345 | $346,954 | $170,026 |
| 2022 | 14 | 1,686 | 2,605 | $399,786 | $195,342 |
| 2021 | 15 | 1,777 | 2,850 | $500,553 | $250,203 |
| 2020 | 15 | 1,908 | 3,131 | $536,305 | $254,108 |
Total Patients
7,123
Total Services
10,931
Medicare Billing
$869,678
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 342 | 719 | $118,635 | $64,700 | 54.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 195 | 289 | $63,002 | $36,181 | 57.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 147 | 147 | $45,570 | $22,065 | 48.4% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 219 | 226 | $22,600 | $9,633 | 42.6% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 221 | 228 | $17,100 | $9,206 | 53.8% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 212 | 220 | $23,100 | $6,219 | 26.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 13 | 36 | $14,796 | $5,930 | 40.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 29 | 52 | $8,320 | $4,706 | 56.6% |
| 94664 | Evaluation of use of breathing device | Office | 2023 | 228 | 260 | $9,100 | $3,260 | 35.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 30 | 50 | $5,500 | $2,936 | 53.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 19 | 19 | $5,795 | $2,546 | 43.9% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 16 | 16 | $8,000 | $1,030 | 12.9% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 44 | 44 | $2,420 | $704.96 | 29.1% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 25 | 26 | $1,430 | $641.68 | 44.9% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 12 | 13 | $1,586 | $267.67 | 16.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 281 | 563 | $92,857 | $52,023 | 56.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 153 | 220 | $47,960 | $27,470 | 57.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 105 | 298 | $47,680 | $23,461 | 49.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 104 | 382 | $42,020 | $21,055 | 50.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 25 | 99 | $40,689 | $16,524 | 40.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 97 | 108 | $32,940 | $16,052 | 48.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 78 | 78 | $24,180 | $12,605 | 52.1% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 189 | 193 | $19,300 | $8,538 | 44.2% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 189 | 192 | $14,400 | $7,671 | 53.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 184 | 187 | $19,635 | $5,279 | 26.9% |
About Dr. Steven Farber, DO
Dr. Steven Farber, DO is a Pulmonary Disease healthcare provider based in Mesa, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1336131382.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Farber, DO has received a total of $21,369 in payments from pharmaceutical and medical device companies, with $7,150 received in 2024. These payments were reported across 933 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($16,089).
As a Medicare-enrolled provider, Farber has provided services to 7,123 Medicare beneficiaries, totaling 10,931 services with total Medicare billing of $869,678. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Mesa, AZ
- Active Since 08/16/2005
- Last Updated 08/09/2023
- Taxonomy Code 207RP1001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1336131382
Products in Payments
- Da Vinci Surgical System (Device) $4,827
- DUPIXENT (Biological) $1,132
- NUCALA (Biological) $1,053
- TRELEGY ELLIPTA (Drug) $938.51
- ORENITRAM (Drug) $700.02
- Prolastin-C Liquid (Biological) $689.07
- Arikayce (Drug) $665.51
- OPSUMIT (Drug) $661.33
- SYMBICORT (Drug) $551.99
- FASENRA (Drug) $485.79
- TEZSPIRE (Biological) $454.88
- BREZTRI (Drug) $414.63
- FASENRA (Biological) $407.94
- ACTHAR (Biological) $389.95
- GLASSIA (Biological) $343.78
- OFEV (Drug) $330.49
- Esbriet (Biological) $305.41
- STIOLTO RESPIMAT (Drug) $283.45
- TYVASO (Drug) $261.03
- UPTRAVI (Drug) $251.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Mesa
Dr. George Parides, Do, DO
Pulmonary Disease — Payments: $1.0M
Pulmonary Disease $1.0M
Dr. Robert Groves, M.d, M.D
Pulmonary Disease — Payments: $4,541
Pulmonary Disease $4,541
G Sulit, Md, MD
Pulmonary Disease — Payments: $4,060
Pulmonary Disease $4,060
Alhassan Badahman, M.d, M.D
Pulmonary Disease — Payments: $3,937
Pulmonary Disease $3,937
Dashant Kavathia, Md, MD
Pulmonary Disease — Payments: $3,271
Pulmonary Disease $3,271
Seyed Javadpoor, Md, MD
Pulmonary Disease — Payments: $3,044
Pulmonary Disease $3,044